Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 1, 2010, Pages 40-52

  Mirzapoiazova, Tamara ^a   Moitra, Jaideep ^a   Moreno Vinasco, Liliana ^b   Sammani, Saad ^b   Turner, Jerry R ^c   Chiang, Eddie T ^b   Evenoski, Carrie ^b   Wang, Ting ^b   Singleton, Patrick A ^b   Huang, Yong ^a   Lussier, Yves A ^a   Watterson, D Martin ^d   Dudek, Steven M ^b   Garcia, Joe G N ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Department of Pathology ^*  (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Endothelial barrier; Endotoxin lipopolysaccharide; Lung injury; Mice; NmMLCK

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; ISOENZYME; LIPOPOLYSACCHARIDE; LIPOSOME; MLC KINASE INHIBITORY PEPTIDE; MYELOPEROXIDASE; MYOSIN LIGHT CHAIN KINASE; PEPTIDE; PROTEIN P53; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LUNG INJURY; LUNG LAVAGE; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TIDAL VOLUME; VENTILATOR INDUCED LUNG INJURY; WILD TYPE;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LIPOSOMES; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PEPTIDYL-DIPEPTIDASE A; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; VENTILATOR-INDUCED LUNG INJURY;

MURINAE; MUS;

EID: 78650649946     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0197OC     Document Type: Article

References (50)

1. Lazar V, Garcia JG. A single human myosin light chain kinase gene (MLCK; MYLK) transcribes multiple nonmuscle isoforms. Genomics 1999;57:256-267.
2. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998;157:294-323. (Pubitemid 28071297)
3. Ma SF, Grigoryev DN, Taylor AD, Nonas S, Sammani S, Ye SQ, Garcia JG. Bioinformatic identification of novel early stress response genes in rodent models of lung injury. Am J Physiol 2005;289:L468-L477.
4. Chopra M, Reuben JS, Sharma AC. Acute lung injury: apoptosis and signaling mechanisms. Exp Biol Med 2009;234:361-371.
5. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol 2001;280:L1168-L1178.
6. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-1500.
7. Garcia JG, Verin AD, Herenyiova M, English D. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J Appl Physiol 1998;84:1817-1821.
8. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 1995;163:510-522.
9. Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JG. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol 2004;31:517-527.
10. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G851-G857.
11. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006;34:487-495.
12. Moitra J, Evenoski C, Sammani S, Wadgaonkar R, Turner JR, Ma SF, Garcia JG. A transgenic mouse with vascular endothelial overexpression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age. Transl Res 2008;151:141-153.
13. Flores C, Ma SF, Maresso K, Ober C, Garcia JG. A variant of the myosin light chain kinase gene is associated with severe asthma in african americans. Genet Epidemiol 2007;31:296-305.
14. Gao L, Grant A, Chi P, Gao P, Stockton M, Watson H, Hansel N, Diette G, Dunston G, Mathias RA, et al. Myosin light chain kinase (MYLK) variants that confer increased risk of sepsis and acute lung injury are associated with asthma and associated phenotypes [abstract]. Annual Meeting of the American Academy of Allergy, Asthma and Immunology, 2007.
15. Desai AA, Hysi P, Garcia JG. Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases. Transl Res 2008;151:181-193.
16. Hong SB, Huang Y, Moreno-Vinasco L, Sammani S, Moitra J, Barnard JW, Ma SF, Mirzapoiazova T, Evenoski C, Reeves RR, et al. Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med 2008;178:605-617.
17. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamburg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701.
18. Owens SE, Graham WV, Siccardi D, Turner JR, Mrsny RJ. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase. Pharm Res 2005;22:703-709.
19. Wainwright MS, Rossi J, Schavocky J, Crawford S, Steinhorn D, Velentza AV, Zasadzki M, Shirinsky V, Jia Y, Haiech J, et al. Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci USA 2003;100:6233-6238.
20. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.Am J Respir Crit Care Med 2004;169:1245-1251. (Pubitemid 38680403)
21. Meyer NJ, Huang Y, Singleton PA, Sammani S, Moitra J, Evenoski CL, Husain AN, Mitra S, Moreno-Vinasco L, Jacobson JR, et al. GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling. FASEB J 2009;3:1325-1337.
22. Peng X, Sammani S, McVerry BJ, Hassoun PM, Garcia JG. Sphingosine 1-phosphate reduces lung vascular permeability in a murine model of LPS-mediated acute lung injury. Am J Respir Crit Care Med 2003;167: A778.
23. Simon BA, Easley RB, Grigoryev DN, Ma SF, Ye SQ, Lavoie T, Tuder RM, Garcia JG. Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury. Am J Physiol 2006;291: L851-L861.
24. Wu Z, Irizarry R, Gentleman R, Martinez-Murillo F, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004;99:909-917.
25. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121.
26. Consortium. The Gene Ontology (GO) Project in 2006. Nucleic Acids Res 2006;34:D322-D326.
27. Draghici S, Khatri P, Bhavsar P, ShahA, Krawetz SA, TainskyMA. Ontotools, the toolkit of the modern biologist: onto-express, onto-compare, onto-design and onto-translate. Nucleic Acids Res 2003;31:3775-3781.
28. Benjamini YHY. On the adaptive control of the false discovery fate in multiple testing with independent statistics. J Educ Behav Stat 2000; 25:60-83.
29. Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, Turner JR. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 2002;123:163-172.
30. Aurrand-Lions M, Johnson-Leger C, Lamagna C, Ozaki H, Kita T, Imhof BA. Junctional adhesion molecules and interendothelial junctions. Cells Tissues Organs 2002;172:152-160.
31. Greer P. Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 2002;3:278-289.
32. Garcia JG, Lazar V, Gilbert-McClain LI, Gallagher PJ, Verin AD. Myosin light chain kinase in endothelium: molecular cloning and regulation. Am J Respir Cell Mol Biol 1997;16:489-494.
33. Wadgaonkar R, Linz-McGillem L, Zaiman AL, Garcia JG. Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity. J Cell Biochem 2005;94:351-364.
34. Goldblum SE, Hennig B, Jay M, Yoneda K, McClain CJ. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect Immun 1989;57:1218-1226.
35. Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR. Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol Toxicol 2004;20:1-14.
36. Essler M, Staddon JM, Weber PC, Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 2000;164:6543-6549.
37. Cui Y, English DK, Siddiqui RA, Heranyiova M, Garcia JG. Activation of endothelial cell phospholipase D by migrating neutrophils. J Investig Med 1997;45:388-393.
38. Clayburgh DR, Musch MW, Leitges M, Fu YX, Turner JR. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest 2006;116:2682-2694.
39. Penn MS, Chisolm GM. Relation between lipopolysaccharide-induced endothelial cell injury and entry of macromolecules into the rat aorta in vivo. Circ Res 1991;68:1259-1269.
40. Moriez R, Salvador-Cartier C, Theodorou V, Fioramonti J, Eutamene H, Bueno L. Myosin light chain kinase is involved in lipopolysaccharideinduced disruption of colonic epithelial barrier and bacterial translocation in rats. Am J Pathol 2005;167:1071-1079.
41. Jacobson JR, Dudek SM, Singleton PA, Kolosova IA, Verin AD, Garcia JG. Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol 2006;291:L289-L295.
42. Ma SF, Moreno-Vinasco L, Moitra J, Wang T, Hysi P, Flores C, Dudek SM, Nicolae DL, Ober C, Watterson MA, et al. Non-muscle myosin light chain kinase is a novel molecular target in murine and human asthma with MYLK polymorphisms conferring ethnic-specific asthma susceptibility. J Invest Med 2008;56:594 (Abstract).
43. Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Natl Rev 2001;2:110-119.
44. Tuschl T. RNA interference and small interfering RNAs. ChemBioChem 2001;2:239-245.
45. Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference- based therapeutics. Nature 2009;457:426-433.
46. Gao L, Flores C, Fan-Ma S, Miller EJ, Moitra J, Moreno L,Wadgaonkar R, Simon B, Brower R, Sevransky J, et al. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl Res 2007;150:18-29.
47. Lingor P, Michel U, Scholl U, Bahr M, Kugler S. Transfection of "naked" Sirna results in endosomal uptake and metabolic impairment in cultured neurons. Biochem Biophys Res Commun 2004;315:1126-1133.
48. Idell S, Gonzalez K, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JG, Griffith DE, Weiland J,Martin TR, et al. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome: contribution of tissue factor associated with factor VII. Am Rev Respir Dis 1987;136:1466-1474.
49. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 2005;280:17286-17293.
50. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care 2008;12:S3.